Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.

@article{Rees2012ProphylacticIC,
  title={Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.},
  author={Johannes B. van Rees and C. Jan Willem Borleffs and J G P Thijssen and Mih{\'a}ly K. de Bie and Lieselot van Erven and Suzanne C Cannegieter and Jeroen J. Bax and Martin Jan Schalij},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2012},
  volume={14 1},
  pages={66-73}
}
AIMS In elderly patients, obscurity remains regarding the benefit of implantable cardioverter-defibrillator (ICD) treatment as primary prevention of sudden cardiac death. This study assesses implant rates, therapy, adverse events, and survival gain in the elderly primary prevention ICD patient. METHODS AND RESULTS A total of 1395 patients treated with an ICD for primary prevention of sudden cardiac death at the Leiden University Medical Center were included and allocated to three groups… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…